FIELD: chemistry.
SUBSTANCE: invention relates to a process for the preparation of (R)-5-bromo-4-(3-amino)piperidin-1-yl)-3-(cyclopropanecarboxamido)-1H-pyrrolo[2,3-b]pyridine of Formula (I): (I) or a pharmaceutically acceptable salt thereof, comprising reacting a compound of Formula (II): (II), wherein X is halogen, with a compound of Formula (III): (III), where R is an amino protecting group, to give a compound of Formula (IV): (IV), nitro-reduction reaction of the compound of Formula (IV) to obtain a compound of Formula (V): (V), reacting a compound of Formula (V) with a compound of Formula (VI): (VI), where R1 is selected from the group consisting of chlorine, fluorine, bromine and OR2, where R2 is selected from the group consisting of cyclopropylcarbonyl, isobutylcarbonyl, isopropylcarbonyl, ethylcarbonyl, methylcarbonyl, 2-pyridyl and N-succinimidyl to give the compound of Formula (VII): (VII) step of deprotecting R in the compound of Formula (VII) with pouring (R)-5-bromo-4-(3-(amino)piperidin-1-yl)-3-(cyclopropanecarboxamido)-1H-pyrrolo[2,3-b]pyridine of Formula (I).
EFFECT: method of preparing a compound is provided.
20 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
INTERMEDIATE CHEMICAL COMPOUNDS AND METHODS FOR PRODUCING COMPOUNDS | 2013 |
|
RU2635359C2 |
COMBINATION OF CHEKPOINT-KINASE 1 INHIBITORS AND WEE 1 KINASE INHIBITORS | 2011 |
|
RU2627841C2 |
INHIBITORS OF CELL CYCLE CHECKPOINT KINASE 1 FOR AMPLIFICATION OF DNA-DAMAGING AGENTS | 2010 |
|
RU2567044C2 |
PYRROLOPYRIDINES AS KINASE INHIBITORS | 2009 |
|
RU2517194C2 |
COMBINED THERAPY WITH TETRACYCLIC QUINOLONE ANALOGUES FOR CANCER TREATMENT | 2016 |
|
RU2752506C2 |
PEPTIDE PROTECTION AGAINST ULTRAVIOLET LIGHT TOXICITY | 2010 |
|
RU2565535C2 |
DUAL ATM AND DNA-PK INHIBITORS FOR ANTITUMOR THERAPY | 2020 |
|
RU2800756C1 |
COMBINATION THERAPY WITH TETRACYCLIC QUINOLONE ANALOGUES FOR TREATMENT OF CANCER | 2016 |
|
RU2786570C2 |
METHOD OF TREATING CANCER USING A COMBINATION OF CHK1 AND ATR INHIBITORS | 2015 |
|
RU2736219C2 |
METHOD FOR PRODUCTION OF HYDROXYLATED CYCLOPENTYL PYRIMIDINE COMPOUNDS | 2013 |
|
RU2643811C2 |
Authors
Dates
2018-11-19—Published
2014-08-21—Filed